Figure EE

See text for description.

In 2018, there were 20,838 unique MSM tested for rectal gonorrhea and/or chlamydia (20,798 for gonorrhea and 20,755 for chlamydia). When compared to urogenital testing, rectal testing occurs less frequently in the majority of jurisdictions. The median positivity for rectal gonorrhea among MSM was 14.8% (range: 7.6%–18.1%) and for rectal chlamydia was 16.1% (range: 10.2%–20.8%) among the SSuN jurisdictions.